TY - JOUR T1 - Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of<em>Helicobacter pylori</em> JF - Gut JO - Gut SP - 454 LP - 460 DO - 10.1136/gut.48.4.454 VL - 48 IS - 4 AU - S Nakamura AU - T Matsumoto AU - H Suekane AU - M Takeshita AU - K Hizawa AU - M Kawasaki AU - T Yao AU - M Tsuneyoshi AU - M Iida AU - M Fujishima Y1 - 2001/04/01 UR - http://gut.bmj.com/content/48/4/454.abstract N2 - BACKGROUND While a close association between gastric mucosa associated lymphoid tissue (MALT) lymphoma and Helicobacter pyloriinfection has been established, there are still cases which do not respond to H pylori eradication.AIMS To investigate the clinicopathological factors which may help predict the therapeutic efficacy of H pylori eradication in gastric MALT lymphoma.PATIENTS Forty one patients with gastric MALT lymphoma, including low and high grade lesions.METHODS After endosonographic staging was determined, H pylori was eradicated in all patients, and the subsequent gastric pathological course was then investigated.RESULTS Complete regression of MALT lymphoma was observed in 29(71%) patients, partial regression in five (12%), and no regression in seven (17%). Twenty six (93%) of 28 MALT lymphomas restricted to the mucosa but only three (23%) of 13 lymphomas which invaded the deep portion of the submucosa or beyond completely regressed. Kaplan-Meier analysis for the probability of complete regression of MALT lymphoma revealed a significant difference between tumours restricted to the mucosa and those invading the submucosa deeply or beyond (p&lt;0.05). Neither the presence of a high grade component, perigastric lymphadenopathy, nor clinical staging prior to eradication correlated with the probability of lymphoma regression.CONCLUSIONS Assessment of deep submucosal invasion by endosonography is valuable for predicting the efficacy of H pylorieradication in gastric MALT lymphoma.MALTmucosa associated lymphoid tissueEUSendoscopic ultrasonographyRLHreactive lymphoid hyperplasia ER -